Will people in conflict affected zones in Africa have access to COVID-19 vaccine? A case of Nigeria.
Int J Health Plann Manage
; 37(4): 1918-1925, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1772691
ABSTRACT
Vaccination is an important and cost-effective disease prevention and control strategy. Over the years, milestone discoveries in vaccine research and development as well as vaccine delivery systems, have contributed to expanded immunisation coverage and reduction in morbidity and mortality associated with vaccine-preventable diseases. While this outstanding development in vaccine delivery continues, there are considerable gaps in access to vaccines among populations living in fragile and conflict-affected zones which appeared to be the fault line of limited vaccine coverage. Despite progress in coronavirus disease 2019 (COVID-19) vaccine development, there are concerns about the feasibility of African countries affected by armed conflict and violence to effectively deliver COVID-19 vaccines at the unprecedented level required to fight against the virus. In this article we discuss the feasibility of access to COVID-19 vaccine among populations in conflict affected areas in Nigeria including methods that can be applied to reach and vaccinate populations in these settings.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Case report
/
Observational study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Journal:
Int J Health Plann Manage
Journal subject:
Health Services Research
/
Health Services
Year:
2022
Document Type:
Article
Affiliation country:
Hpm.3474
Similar
MEDLINE
...
LILACS
LIS